• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Inverse Relationship between Soluble RAGE and Risk for Bronchopulmonary Dysplasia.

作者信息

Benjamin John T, van der Meer Riet, Slaughter James C, Steele Steven, Plosa Erin J, Sucre Jennifer M, Moore Paul E, Aschner Judy L, Blackwell Timothy S, Young Lisa R

机构信息

1 Vanderbilt University Medical Center Nashville, Tennessee.

2 Children's Hospital at Montefiore/Albert Einstein College of Medicine Bronx, New York and.

出版信息

Am J Respir Crit Care Med. 2018 Apr 15;197(8):1083-1086. doi: 10.1164/rccm.201707-1445LE.

DOI:10.1164/rccm.201707-1445LE
PMID:29035091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5909162/
Abstract
摘要

相似文献

1
Inverse Relationship between Soluble RAGE and Risk for Bronchopulmonary Dysplasia.可溶性晚期糖基化终末产物受体与支气管肺发育不良风险之间的负相关关系。
Am J Respir Crit Care Med. 2018 Apr 15;197(8):1083-1086. doi: 10.1164/rccm.201707-1445LE.
2
Early Identification of Bronchopulmonary Dysplasia Using Novel Biomarkers by Proteomic Screening.通过蛋白质组学筛选利用新型生物标志物早期识别支气管肺发育不良
Am J Respir Crit Care Med. 2018 Apr 15;197(8):1076-1080. doi: 10.1164/rccm.201706-1218LE.
3
Association of increased cord blood soluble endoglin with the development of bronchopulmonary dysplasia in preterm infants with maternal preeclampsia.脐血可溶性内皮糖蛋白升高与患有子痫前期母亲的早产儿支气管肺发育不良发生的相关性
Pregnancy Hypertens. 2018 Jul;13:148-153. doi: 10.1016/j.preghy.2018.06.002. Epub 2018 Jun 9.
4
[Parameters in early prediction of bronchopulmonary dysplasia in preterm infants].[早产儿支气管肺发育不良早期预测的参数]
Harefuah. 1998 Jul;135(1-2):47-51.
5
Bronchopulmonary dysplasia.支气管肺发育不良
Mead Johnson Symp Perinat Dev Med. 1988(33):43-53.
6
Brain Natriuretic Propeptide as an Early Marker of Bronchopulmonary Dysplasia or Death in the Preterm Newborn.脑钠肽作为早产儿支气管肺发育不良或死亡的早期标志物
Klin Padiatr. 2017 Jul;229(4):223-228. doi: 10.1055/s-0043-111597. Epub 2017 Jul 17.
7
[Bronchopulmonary dysplasia].支气管肺发育不良
Kinderkrankenschwester. 2008 Aug;27(8):327-30.
8
Physiologically redefining bronchopulmonary dysplasia.从生理学角度重新定义支气管肺发育不良。
Pediatrics. 2005 Mar;115(3):830-1; author reply 831. doi: 10.1542/peds.2004-2524.
9
[Review of the definition of bronchopulmonary dysplasia].[支气管肺发育不良的定义综述]
Arch Pediatr. 2005 Nov;12 Spec No 3:8-9.
10
Role of antioxidant nutrients and lipid peroxidation in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia.抗氧化营养素和脂质过氧化在呼吸窘迫综合征和支气管肺发育不良早产儿中的作用。
Am J Perinatol. 2003 Feb;20(2):97-107. doi: 10.1055/s-2003-38315.

引用本文的文献

1
Prospective epigenome and transcriptome analyses of cord and peripheral blood from preterm infants at risk of bronchopulmonary dysplasia.前瞻性分析早产儿围生期脐带和外周血的基因组和转录组，以探讨其发生支气管肺发育不良的风险。
Sci Rep. 2023 Jul 28;13(1):12262. doi: 10.1038/s41598-023-39313-0.
2
The AGE-RAGE Axis and the Pathophysiology of Multimorbidity in COPD.晚期糖基化终末产物-晚期糖基化终末产物受体轴与慢性阻塞性肺疾病的多病共存病理生理学
J Clin Med. 2023 May 9;12(10):3366. doi: 10.3390/jcm12103366.
3
Biomarker Potential of the Soluble Receptor for Advanced Glycation End Products to Predict Bronchopulmonary Dysplasia in Premature Newborns.晚期糖基化终产物可溶性受体预测早产儿支气管肺发育不良的生物标志物潜力
Front Pediatr. 2021 Apr 29;9:649526. doi: 10.3389/fped.2021.649526. eCollection 2021.
4
Serum AGE/RAGEs as potential biomarker in idiopathic pulmonary fibrosis.血清 AGE/RAGEs 作为特发性肺纤维化的潜在生物标志物。
Respir Res. 2018 Nov 8;19(1):215. doi: 10.1186/s12931-018-0924-7.

本文引用的文献

1
Plasma Soluble Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis.特发性肺纤维化患者血浆可溶性晚期糖基化终产物受体。
Ann Am Thorac Soc. 2017 May;14(5):628-635. doi: 10.1513/AnnalsATS.201606-485OC.
2
Soluble Forms and Ligands of the Receptor for Advanced Glycation End-Products in Patients with Acute Respiratory Distress Syndrome: An Observational Prospective Study.急性呼吸窘迫综合征患者晚期糖基化终产物受体的可溶性形式和配体：一项前瞻性观察研究。
PLoS One. 2015 Aug 14;10(8):e0135857. doi: 10.1371/journal.pone.0135857. eCollection 2015.
3
Circulating soluble receptor for advanced glycation end products (sRAGE) as a biomarker of emphysema and the RAGE axis in the lung.循环可溶性晚期糖基化终产物受体 (sRAGE) 作为肺气肿的生物标志物及肺内 RAGE 轴。
Am J Respir Crit Care Med. 2015 Oct 1;192(7):785-92. doi: 10.1164/rccm.201501-0137PP.
4
Understanding the Short- and Long-Term Respiratory Outcomes of Prematurity and Bronchopulmonary Dysplasia.了解早产和支气管肺发育不良的短期和长期呼吸结局。
Am J Respir Crit Care Med. 2015 Jul 15;192(2):134-56. doi: 10.1164/rccm.201412-2142PP.
5
Prematurity and respiratory outcomes program (PROP): study protocol of a prospective multicenter study of respiratory outcomes of preterm infants in the United States.早产与呼吸结局项目（PROP）：美国一项关于早产儿呼吸结局的前瞻性多中心研究方案
BMC Pediatr. 2015 Apr 10;15:37. doi: 10.1186/s12887-015-0346-3.
6
Associations between maternal and infant morbidities and sRAGE within the first week of life in extremely preterm infants.极早产儿生后第一周母儿并发症与 sRAGE 的相关性研究。
PLoS One. 2013 Dec 6;8(12):e82537. doi: 10.1371/journal.pone.0082537. eCollection 2013.
7
Soluble RAGE is deficient in neutrophilic asthma and COPD.中性粒细胞性哮喘和 COPD 患者血清可溶性 RAGE 缺乏。
Eur Respir J. 2012 Mar;39(3):721-9. doi: 10.1183/09031936.00022011. Epub 2011 Sep 15.
8
Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD.慢性阻塞性肺疾病患者的晚期糖基化终产物及其受体（RAGE）增加。
Respir Med. 2011 Mar;105(3):329-36. doi: 10.1016/j.rmed.2010.11.001. Epub 2010 Nov 26.
9
High-mobility group box-1 protein in tracheal aspirates from premature infants: relationship with bronchopulmonary dysplasia and steroid therapy.早产儿气管抽吸物中高迁移率族蛋白 B1 与支气管肺发育不良及激素治疗的关系。
J Perinatol. 2010 Sep;30(9):610-5. doi: 10.1038/jp.2010.16. Epub 2010 Feb 25.
10
The receptor for advanced glycation end products (RAGE) and the lung.晚期糖基化终末产物受体（RAGE）与肺脏
J Biomed Biotechnol. 2010;2010:917108. doi: 10.1155/2010/917108. Epub 2010 Jan 19.